Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016

  • ID: 3773892
  • Clinical Trials
  • Region: Global
  • 93 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AbbVie In
  • Chemo Espana, S.A.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • ImmunoGen, Inc.
  • MORE
Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016

Summary

The clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016" provides an overview of Wilms' Tumor (Nephroblastoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor (Nephroblastoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie In
  • Chemo Espana, S.A.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • ImmunoGen, Inc.
  • MORE
List of Tables

List of Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Wilms' Tumor (Nephroblastoma)

Apr 14, 2016: Juno Therapeutics Announces First clinical data for the WT-1 TCR product candidate, JTCR016 at the American Association for Cancer Research Annual Meeting

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About

Contact Us

Disclaimer

Source

List of Tables

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Region, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*

Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, G7 Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*

Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, E7 Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Region (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*

Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, G7 Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*

Proportion of Wilms' Tumor (Nephroblastoma) to Oncology Clinical Trials, E7 Countries (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Phase (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Children’s Cancer and Leukaemia Group
Children's Healthcare of Atlanta Inc.
GlaxoSmithKline Plc
ImmunoGen, Inc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Chemo Espana, S.A.
Celtic Pharmaceutical Holdings L.P.
Cambridge Laboratories Limited
AbbVie In
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll